1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated patient-derived models delineate individualized therapeutic vulnerabilities of pancreatic cancer
    Journal Article

    Witkiewicz, A. K.; Balaji, U.; Eslinger, C.; McMillan, E.; Conway, W.; Posner, B.; Mills, G. B.; O'Reilly, E. M.; Knudsen, E. S.
    Cell Reports (2016)

    Fulltext@MSK | Save
  • Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
    Journal Article

    Rebbeck, T. R.; Friebel, T. M.; Mitra, N.; Wan, F.; Chen, S.; Andrulis, I. L.; Apostolou, P.; Arnold, N.; Arun, B. K.; Barrowdale, D.; more...
    Breast Cancer Research (2016)

    Fulltext@MSK | Save
  • Have adjuvant tyrosine kinase inhibitors lost their shine?
    Journal Article

    Sabari, J. K.; Chaft, J. E.
    Annals of Translational Medicine (2016)

    Fulltext@MSK | Save
  • Nivolumab monotherapy in metastatic urothelial cancer (mUC): Efficacy (by PD-L1 expression) and safety results from the CheckMate 032 study
    Meeting Abstract

    Jaeger, D.; Sharma, P.; Bono, P.; Kim, J.; Spiliopoulou, P.; Calvo, E.; Pillai, R. N.; Ott, P. A.; de Braud, F.; Morse, M.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Impact of key prognostic factors on long-term overall survival in BRAF(V600)-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study
    Meeting Abstract

    Hauschild, A.; Chapman, P. B.; Robert, C.; Larkin, J.; Haanen, J. B.; Ribas, A.; Hogg, D.; Hamid, O.; Ascierto, P. A.; Testori, A.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • TERT promoter mutations in patients with BRAF(V600)-mutated melanoma treated with vemurafenib or cobimetinib combined with vemurafenib
    Meeting Abstract

    Wongchenko, M. J.; Larkin, J.; McArthur, G. A.; Ribas, A.; Dreno, B.; Chapman, P. B.; Maio, M.; Garbe, C.; Robert, C.; Lu, W.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • Design of a phase 3, international, prospective, randomized, double-blind, placebo (PBO) controlled study assessing efficacy and safety of lanreotide autogel/depot (LAN) 120 mg in patients with well-differentiated, advanced typical and atypical lung NETs
    Meeting Abstract

    Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Mirakhur, B.; Massien, C.; Caplin, M.; Baudin, E.
    Neuroendocrinology (2016)

    Fulltext@MSK | Save
  • Correlation of response with overall survival (OS) for nivolumab vs everolimus in advanced renal cell carcinoma (aRCC): Results from the phase III CheckMate 025 study
    Meeting Abstract

    Grünwald, V.; Motzer, R. J.; Sharma, P.; Escudier, B.; McDermott, D. F.; George, S.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Plimack, E. R.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • Improvements in quality of life and overall survival in patients with advanced renal cell carcinoma treated with nivolumab vs everolimus in the phase Ill CheckMate 025 study
    Meeting Abstract

    Grünwald, V.; Cella, D.; Nathan, P.; Doan, J.; Dastahi, H.; Taylor, F.; Bennett, B.; DeRosa, M.; Berry, S.; Broglio, K.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save
  • CheckMate 017 and 057 studies of nivolumab vs docetaxel in patients with advanced NSCLC: 2-year-update and exploratory cytokine profile analyses
    Meeting Abstract

    Eberhardt, W. E. E.; Borghaei, H.; Brahmer, J. R.; Horn, L.; Ready, N.; Steins, M.; Felip, E.; Paz-Ares, L. G.; Arrieta, O.; Barlesi, F.; more...
    Oncology Research and Treatment (2016)

    Fulltext@MSK | Save